v3.25.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Sale of product $ 3,655,320 $ 3,169,233 $ 6,894,220 $ 6,073,691
Cost of product 1,513,761 1,151,722 2,720,624 2,190,069
Gross profit 2,141,559 2,017,511 4,173,596 3,883,622
Operating costs and expenses:        
Salaries and contract labor 1,088,832 961,842 2,208,158 1,902,345
General, administrative, and consulting 1,084,907 1,047,063 1,955,931 2,050,620
Research and development 102,661 188,730 209,364 376,977
Total operating expenses 2,276,400 2,197,635 4,373,453 4,329,942
Net operating loss (134,841) (180,124) (199,857) (446,320)
Other income (expense):        
Other income 38,095 (5,344) 52,444 155,376
Interest income 18,768 33,531 40,592 66,259
Interest expense (82,807) (81,508) (166,658) (162,811)
Total other (expense) income (25,944) (53,321) (73,622) 58,824
Net Loss $ (160,785) $ (233,445) $ (273,479) $ (387,496)
Net loss per common share - basic: (in dollars per share) $ 0 $ 0 $ 0 $ 0
Net loss per common share - diluted: (in dollars per share) $ 0 $ 0 $ 0 $ 0
Weighted average common shares outstanding - basic (in shares) 527,355,415 522,779,643 525,718,720 521,473,413
Weighted average common shares outstanding - diluted (in shares) 527,355,415 522,779,643 525,718,720 521,473,413